A fourth study suggests that Gal-3 has multiple roles in NASH, with CD68/Gal-3+ cells decreasing with severity of steatosis and NASH and α-smooth muscle actin/Gal-3+ cells increasing with severity of fibrosis [24]. The gene discussed is CD68; the disease is metabolic dysfunction-associated steatohepatitis.